ATE392900T1 - Verwendung unverdaulicher, polymerer schäume zum abkapseln eingenommener stoffe, und dadurch verhinderung ihre aufnahme durch den körper - Google Patents
Verwendung unverdaulicher, polymerer schäume zum abkapseln eingenommener stoffe, und dadurch verhinderung ihre aufnahme durch den körperInfo
- Publication number
- ATE392900T1 ATE392900T1 AT02715032T AT02715032T ATE392900T1 AT E392900 T1 ATE392900 T1 AT E392900T1 AT 02715032 T AT02715032 T AT 02715032T AT 02715032 T AT02715032 T AT 02715032T AT E392900 T1 ATE392900 T1 AT E392900T1
- Authority
- AT
- Austria
- Prior art keywords
- enapsule
- indigestible
- absorption
- preventing
- polymeric foam
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/745—Polymers of hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/745—Polymers of hydrocarbons
- A61K31/75—Polymers of hydrocarbons of ethene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27705801P | 2001-03-19 | 2001-03-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE392900T1 true ATE392900T1 (de) | 2008-05-15 |
Family
ID=23059227
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02715032T ATE392900T1 (de) | 2001-03-19 | 2002-03-01 | Verwendung unverdaulicher, polymerer schäume zum abkapseln eingenommener stoffe, und dadurch verhinderung ihre aufnahme durch den körper |
Country Status (14)
Country | Link |
---|---|
US (1) | US20030072804A1 (de) |
EP (1) | EP1372673B1 (de) |
JP (1) | JP4477826B2 (de) |
CN (1) | CN1296053C (de) |
AR (1) | AR033871A1 (de) |
AT (1) | ATE392900T1 (de) |
AU (1) | AU2002247253B2 (de) |
CA (1) | CA2437481C (de) |
DE (1) | DE60226217T2 (de) |
ES (1) | ES2303545T3 (de) |
HK (1) | HK1069329A1 (de) |
MX (1) | MXPA03008499A (de) |
MY (1) | MY134067A (de) |
WO (1) | WO2002074343A2 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8372430B2 (en) | 2002-12-17 | 2013-02-12 | The Procter & Gamble Company | Compositions, methods, and kits useful for the alleviation of gastrointestinal effects |
JP5383976B2 (ja) * | 2003-09-08 | 2014-01-08 | エフエムシー バイオポリマー エイエス | ゲル化バイオ重合体基材発泡体 |
US20080089933A1 (en) * | 2006-10-16 | 2008-04-17 | Amir Alon | Device and method for reducing calorie intake |
WO2005074378A2 (en) * | 2004-02-10 | 2005-08-18 | Itzhak Katz | Device and method for reducing calorie intake |
WO2007017842A2 (en) * | 2005-08-09 | 2007-02-15 | Tylerton International Inc. | Satiety |
WO2012061422A2 (en) * | 2010-11-02 | 2012-05-10 | The Johns Hopkins University | Gastric sponge system and use thereof |
CA2828747C (en) | 2011-03-01 | 2016-05-10 | The Procter & Gamble Company | Porous disintegratable solid substrate for personal health care applications |
US8722066B2 (en) | 2011-03-29 | 2014-05-13 | Primigenia, LLC | Devices and methods for weight control and weight loss |
JP6230592B2 (ja) * | 2012-03-27 | 2017-11-15 | テラテクネ インコーポレイティッド | 高多孔性セルローススポンジ |
EP2916913A4 (de) * | 2012-03-27 | 2016-03-02 | Primigenia Llc | Hochporöser cellulosischer schwamm |
CN104622851B (zh) * | 2015-03-13 | 2017-09-12 | 山东省药学科学院 | 一种减肥胶囊及其制备方法 |
WO2017031468A1 (en) * | 2015-08-20 | 2017-02-23 | The Johns Hopkins University | Gastric device and method of use thereof |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3600186A (en) * | 1968-04-23 | 1971-08-17 | Procter & Gamble | Low calorie fat-containing food compositions |
GB1302548A (de) * | 1969-07-28 | 1973-01-10 | ||
US3980770A (en) * | 1971-06-04 | 1976-09-14 | Pharmacia Aktiebolag | Polymerization products containing amino groups useful in serum cholesterol level control |
US3923972A (en) * | 1971-10-12 | 1975-12-02 | Monsanto Co | Method of lowering blood cholesterol level |
US4211765A (en) * | 1971-10-12 | 1980-07-08 | Monsanto Company | Method for controlling obesity |
US4039489A (en) * | 1972-02-22 | 1977-08-02 | Nasa | Oil and fat absorbing polymers |
FI54811C (fi) * | 1972-06-03 | 1979-03-12 | Vega Jose Manuel Regife | Foerfarande foer tillvaratagning och rening av zink fraon zinkhaltiga loesningar |
US3980968A (en) * | 1975-01-02 | 1976-09-14 | Zenith Radio Corporation | Non-proportionate AFC system |
US4005195A (en) * | 1976-02-12 | 1977-01-25 | The Procter & Gamble Company | Compositions for treating hypercholesterolemia |
US4223023A (en) * | 1978-10-12 | 1980-09-16 | Ivan Furda | Nonabsorbable lipid binder |
FR2485548A1 (fr) * | 1980-06-30 | 1981-12-31 | Lhd Lab Hygiene Dietetique | Procede de preparation d'un polymere de structure tridimensionnelle du type polyurethane reticule, produit obtenu selon ce procede et son application en tant qu'agent gonflant, notamment en therapeutique |
US4432968A (en) * | 1980-10-20 | 1984-02-21 | The Dow Chemical Company | Weight control with fat imbibing polymers |
US4401682A (en) * | 1981-07-31 | 1983-08-30 | Battista Orlando A | Expandable low calorie compositions |
CA1247547A (en) * | 1983-06-22 | 1988-12-28 | Paul Hadvary | Leucine derivatives |
US6077556A (en) * | 1989-04-10 | 2000-06-20 | The Procter & Gamble Company | Solid, nondigestible, fat-like compounds |
US5603950A (en) * | 1990-08-14 | 1997-02-18 | Ratjen; Werner | Agent for oral intake |
US5260345A (en) * | 1991-08-12 | 1993-11-09 | The Procter & Gamble Company | Absorbent foam materials for aqueous body fluids and absorbent articles containing such materials |
US5268224A (en) * | 1991-08-12 | 1993-12-07 | The Procter & Gamble Company | Absorbent foam materials for aqueous body fluids and absorbent articles containing such materials |
JP2667351B2 (ja) * | 1992-03-24 | 1997-10-27 | 麒麟麦酒株式会社 | 食餌脂質消化吸収阻害剤および飲食品 |
CA2098167C (en) * | 1992-06-24 | 2006-12-19 | Dorothea Isler | Foodstuffs and feedstuffs containing a lipase inhibitor |
AU682014B2 (en) * | 1992-10-30 | 1997-09-18 | Procter & Gamble Company, The | Nondigestible fat compositions containing solid polyol polyester polymer for passive oil loss control |
JPH08502657A (ja) * | 1992-10-30 | 1996-03-26 | ザ、プロクター、エンド、ギャンブル、カンパニー | 受動的オイルロスコントロール剤としてポリオールポリエステルハードストック及び結晶調節剤の共結晶化ブレンドを含有した非消化性脂肪組成物 |
US5290820A (en) * | 1993-07-29 | 1994-03-01 | Shell Oil Company | Process for preparing low density porous crosslinked polymeric materials |
US5650222A (en) * | 1995-01-10 | 1997-07-22 | The Procter & Gamble Company | Absorbent foam materials for aqueous fluids made from high internal phase emulsions having very high water-to-oil ratios |
US5563179A (en) * | 1995-01-10 | 1996-10-08 | The Proctor & Gamble Company | Absorbent foams made from high internal phase emulsions useful for acquiring and distributing aqueous fluids |
US5750585A (en) * | 1995-04-04 | 1998-05-12 | Purdue Research Foundation | Super absorbent hydrogel foams |
US6271278B1 (en) * | 1997-05-13 | 2001-08-07 | Purdue Research Foundation | Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties |
US6048908A (en) * | 1997-06-27 | 2000-04-11 | Biopore Corporation | Hydrophilic polymeric material |
DE19739031A1 (de) * | 1997-09-05 | 1999-03-11 | Suwelack Nachf Dr Otto | Mittel zur peroralen Verabreichung, seine Herstellung und Verwendung |
CN1152680C (zh) * | 1998-08-14 | 2004-06-09 | 霍夫曼-拉罗奇有限公司 | 含有脂酶抑制剂和壳聚糖的药物组合物 |
JP2003508468A (ja) * | 1999-09-06 | 2003-03-04 | バイゼル ギュンター | 長時間持続性の満腹効果を得るための架橋された薬剤及びその製法 |
DE19942365A1 (de) * | 1999-09-06 | 2001-03-15 | Guenther Beisel | Mittel zur Stimulanz der Darmtätigkeit sowie Verfahren zu dessen Herstellung |
CA2383996A1 (en) * | 1999-09-06 | 2001-03-15 | Gunther Beisel | Agent for stimulating bowel function and method for producing the same |
US6251421B1 (en) * | 2000-09-25 | 2001-06-26 | Sarfaraz K. Niazi | Pharmaceutical composition containing psyllium fiber and a lipase inhibitor |
DE10062624A1 (de) * | 2000-12-15 | 2002-06-20 | Werner Ratjen | Oral verabreichbarer Stoff mit schwammartiger Struktur |
-
2002
- 2002-02-26 US US10/083,218 patent/US20030072804A1/en not_active Abandoned
- 2002-03-01 AU AU2002247253A patent/AU2002247253B2/en not_active Ceased
- 2002-03-01 EP EP02715032A patent/EP1372673B1/de not_active Expired - Lifetime
- 2002-03-01 MX MXPA03008499A patent/MXPA03008499A/es active IP Right Grant
- 2002-03-01 CA CA2437481A patent/CA2437481C/en not_active Expired - Fee Related
- 2002-03-01 ES ES02715032T patent/ES2303545T3/es not_active Expired - Lifetime
- 2002-03-01 CN CNB028065352A patent/CN1296053C/zh not_active Expired - Fee Related
- 2002-03-01 JP JP2002573050A patent/JP4477826B2/ja not_active Expired - Lifetime
- 2002-03-01 WO PCT/US2002/006529 patent/WO2002074343A2/en active IP Right Grant
- 2002-03-01 DE DE60226217T patent/DE60226217T2/de not_active Expired - Lifetime
- 2002-03-01 AT AT02715032T patent/ATE392900T1/de not_active IP Right Cessation
- 2002-03-19 MY MYPI20020971A patent/MY134067A/en unknown
- 2002-03-19 AR ARP020100969A patent/AR033871A1/es not_active Application Discontinuation
-
2005
- 2005-03-07 HK HK05101946A patent/HK1069329A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60226217D1 (de) | 2008-06-05 |
MY134067A (en) | 2007-11-30 |
CN1531437A (zh) | 2004-09-22 |
JP4477826B2 (ja) | 2010-06-09 |
AU2002247253B2 (en) | 2006-02-02 |
AR033871A1 (es) | 2004-01-07 |
WO2002074343A3 (en) | 2003-03-13 |
EP1372673B1 (de) | 2008-04-23 |
CA2437481A1 (en) | 2002-09-26 |
MXPA03008499A (es) | 2003-12-08 |
ES2303545T3 (es) | 2008-08-16 |
JP2004526732A (ja) | 2004-09-02 |
DE60226217T2 (de) | 2009-05-14 |
HK1069329A1 (en) | 2005-05-20 |
EP1372673A2 (de) | 2004-01-02 |
US20030072804A1 (en) | 2003-04-17 |
CN1296053C (zh) | 2007-01-24 |
CA2437481C (en) | 2010-11-02 |
WO2002074343A2 (en) | 2002-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX276488B (es) | Regeneracion de fluidos de tratamiento que contienen gas acido. | |
MX285679B (es) | Composicion de resina absorbente de agua y metodo de produccion de la misma. | |
IS8267A (is) | [1,8]naftýridín-2-ón og tengd efnasambönd til notkunar við meðferð á geðklofa | |
PT1507498E (pt) | Corpo absorvente para aplicar no corpo humano | |
DK1298281T3 (da) | Stimulering ved syrebehandling med en skumblanding i borehullet | |
DE60308431D1 (de) | Geschäumte Säurebehandlungsflüssigkeit | |
DK1684823T3 (da) | Sikkerhedsspinalkateter | |
IL174994A0 (en) | Pyrimidin - 4 - yl - 3, 4 - thione compounds and their use in therapy | |
GB0515815D0 (en) | Well treatment fluid | |
DE602004028934D1 (de) | Benzoä4,5üthienoä2,3-düpyrimidin-4-one und ihre therapeutische verwendung | |
ATE392900T1 (de) | Verwendung unverdaulicher, polymerer schäume zum abkapseln eingenommener stoffe, und dadurch verhinderung ihre aufnahme durch den körper | |
WO2004074243A3 (en) | Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands | |
CY1108808T1 (el) | Ενωσεις μοτιλιδης | |
MXPA03008634A (es) | Nuevos compuestos de dihidropirimidina ciano sustituidos y su uso para tratar enfermedades. | |
ZA200509966B (en) | The treatment of water containing dissolved gases | |
WO2006088797A3 (en) | Portable water purifier | |
DK1670482T4 (da) | Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme | |
EP1613318A4 (de) | Verbindungen und ihre verwendung zur behandlung von diabetes und verwandten erkrankungen | |
GB0314242D0 (en) | Fluid treatment | |
FR2870577B1 (fr) | Element d'absorption | |
EP1725869A4 (de) | Man2as als modifikatoren des iger-wegs und verwendungsverfahren | |
GB2409159B (en) | A preparation for use in the treatment of mud fever in horses | |
NO20040815L (no) | Anvendelse av antroquinoner i behandling av nyresykdom. | |
Phelps | The relationship of family structure, family functioning, and parental supervision to adolescent substance use | |
GB0308285D0 (en) | Improvements in or relating to the treatment of fabric |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |